CMS assists medical device manufacturers, biotechnology companies, food and cosmetics manufacturers, start-ups, service companies, hospitals and pharmacies as well as players in the research-based pharmaceutical industry. The dirverse client roster benefits from cross-practice cooperation. The practice advises on regulatory and licensing matters – including recent cooperations between manufacturers of pharmaceuticals and medical devices – as well as on medicinal cannabis, transactions and digital healthcare topics, including related data protection issues. This is complemented by capacities in contentious topics under competition and pharmaceutical advertising law. Jens Wagner (pharmaceuticals, biotechnology, medical devices and dietary supplements as well as IP) heads the team from Hamburg.
Testimonials
Collated independently by Legal 500 research team.
- 'CMS advises us at various locations and in numerous legal areas and is one of our most important external legal advisors.'
- 'What we particularly appreciate about CMS is the pragmatic and practice-oriented approach, the service orientation, the very high professional quality and the distinctive industry expertise.'
Key clients
- Bayer AG
- Bloomwell Group
Work highlights
- Advising GE Healthcare on the AMNOG benefit assessment following the new approval of a drug, and representing it in landmark proceedings before the Federal Social Court.
- Regulatory, contractual and compliance advice to the Bloomwell Group on structuring the business model for the telemedicine, wholesale and online mail order branches for medicinal cannabis.